nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—PTGER4—pleura—sarcoma	0.0842	0.156	CbGeAlD
Dinoprostone—PTGIR—pulmonary artery—sarcoma	0.0297	0.055	CbGeAlD
Dinoprostone—PTGER3—mammary gland—sarcoma	0.0106	0.0197	CbGeAlD
Dinoprostone—PTGIR—endothelium—sarcoma	0.00929	0.0172	CbGeAlD
Dinoprostone—PTGER2—myometrium—sarcoma	0.00907	0.0168	CbGeAlD
Dinoprostone—PTGER4—hematopoietic system—sarcoma	0.00764	0.0142	CbGeAlD
Dinoprostone—PTGER3—myometrium—sarcoma	0.00754	0.014	CbGeAlD
Dinoprostone—PTGER4—connective tissue—sarcoma	0.00736	0.0136	CbGeAlD
Dinoprostone—SLC51B—tendon—sarcoma	0.00694	0.0128	CbGeAlD
Dinoprostone—PTGER4—smooth muscle tissue—sarcoma	0.00673	0.0125	CbGeAlD
Dinoprostone—HPGDS—myometrium—sarcoma	0.00652	0.0121	CbGeAlD
Dinoprostone—HPGDS—embryo—sarcoma	0.00627	0.0116	CbGeAlD
Dinoprostone—PTGER3—connective tissue—sarcoma	0.00623	0.0115	CbGeAlD
Dinoprostone—PTGFR—myometrium—sarcoma	0.00603	0.0112	CbGeAlD
Dinoprostone—SLCO4A1—mammary gland—sarcoma	0.00602	0.0112	CbGeAlD
Dinoprostone—ABCC5—mammary gland—sarcoma	0.00599	0.0111	CbGeAlD
Dinoprostone—PTGER2—uterus—sarcoma	0.00588	0.0109	CbGeAlD
Dinoprostone—PTGER4—uterus—sarcoma	0.00577	0.0107	CbGeAlD
Dinoprostone—SLC51B—testis—sarcoma	0.00574	0.0106	CbGeAlD
Dinoprostone—PTGER3—smooth muscle tissue—sarcoma	0.0057	0.0106	CbGeAlD
Dinoprostone—HPGDS—hematopoietic system—sarcoma	0.0056	0.0104	CbGeAlD
Dinoprostone—SLC51B—liver—sarcoma	0.00543	0.0101	CbGeAlD
Dinoprostone—HPGDS—connective tissue—sarcoma	0.00539	0.00998	CbGeAlD
Dinoprostone—PTGER4—lymphoid tissue—sarcoma	0.00538	0.00997	CbGeAlD
Dinoprostone—SLCO1B1—mammary gland—sarcoma	0.0053	0.00981	CbGeAlD
Dinoprostone—PTGER2—tendon—sarcoma	0.00515	0.00955	CbGeAlD
Dinoprostone—PTGER4—tendon—sarcoma	0.00506	0.00937	CbGeAlD
Dinoprostone—PTGER2—bone marrow—sarcoma	0.00499	0.00925	CbGeAlD
Dinoprostone—SLC51A—tendon—sarcoma	0.00497	0.00921	CbGeAlD
Dinoprostone—PTGER3—uterus—sarcoma	0.00489	0.00906	CbGeAlD
Dinoprostone—SLCO3A1—myometrium—sarcoma	0.00469	0.00869	CbGeAlD
Dinoprostone—SLCO2B1—mammary gland—sarcoma	0.00468	0.00868	CbGeAlD
Dinoprostone—SLCO2A1—myometrium—sarcoma	0.00464	0.0086	CbGeAlD
Dinoprostone—PTGIR—hematopoietic system—sarcoma	0.00456	0.00845	CbGeAlD
Dinoprostone—PTGFR—smooth muscle tissue—sarcoma	0.00456	0.00845	CbGeAlD
Dinoprostone—PTGIR—connective tissue—sarcoma	0.00439	0.00814	CbGeAlD
Dinoprostone—SLCO4A1—myometrium—sarcoma	0.00427	0.00791	CbGeAlD
Dinoprostone—PTGER2—testis—sarcoma	0.00427	0.00791	CbGeAlD
Dinoprostone—SLCO3A1—seminal vesicle—sarcoma	0.00424	0.00785	CbGeAlD
Dinoprostone—HPGDS—uterus—sarcoma	0.00423	0.00783	CbGeAlD
Dinoprostone—SLCO2A1—seminal vesicle—sarcoma	0.00419	0.00777	CbGeAlD
Dinoprostone—PTGER4—testis—sarcoma	0.00419	0.00776	CbGeAlD
Dinoprostone—SLC51A—testis—sarcoma	0.00412	0.00762	CbGeAlD
Dinoprostone—PTGIR—smooth muscle tissue—sarcoma	0.00402	0.00744	CbGeAlD
Dinoprostone—CYP11A1—hematopoietic system—sarcoma	0.00395	0.00731	CbGeAlD
Dinoprostone—HPGDS—lymphoid tissue—sarcoma	0.00394	0.0073	CbGeAlD
Dinoprostone—PTGFR—uterus—sarcoma	0.00391	0.00724	CbGeAlD
Dinoprostone—SLC51A—liver—sarcoma	0.00389	0.00721	CbGeAlD
Dinoprostone—SLCO4A1—seminal vesicle—sarcoma	0.00386	0.00715	CbGeAlD
Dinoprostone—CYP11A1—connective tissue—sarcoma	0.0038	0.00704	CbGeAlD
Dinoprostone—HPGDS—tendon—sarcoma	0.0037	0.00686	CbGeAlD
Dinoprostone—HPGDS—bone marrow—sarcoma	0.00359	0.00665	CbGeAlD
Dinoprostone—PTGER3—testis—sarcoma	0.00355	0.00657	CbGeAlD
Dinoprostone—SLCO2A1—skin of body—sarcoma	0.00347	0.00642	CbGeAlD
Dinoprostone—PTGFR—tendon—sarcoma	0.00343	0.00635	CbGeAlD
Dinoprostone—Deafness—Vincristine—sarcoma	0.00341	0.00803	CcSEcCtD
Dinoprostone—Urinary retention—Thiotepa—sarcoma	0.00327	0.0077	CcSEcCtD
Dinoprostone—Cardiac arrest—Thiotepa—sarcoma	0.00327	0.0077	CcSEcCtD
Dinoprostone—SLCO1B1—hematopoietic system—sarcoma	0.00323	0.00598	CbGeAlD
Dinoprostone—Dehydration—Thiotepa—sarcoma	0.00319	0.00753	CcSEcCtD
Dinoprostone—PTGER2—lymph node—sarcoma	0.00309	0.00573	CbGeAlD
Dinoprostone—HPGDS—testis—sarcoma	0.00307	0.00568	CbGeAlD
Dinoprostone—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00307	0.00723	CcSEcCtD
Dinoprostone—SLCO3A1—cardiac atrium—sarcoma	0.00306	0.00566	CbGeAlD
Dinoprostone—PTGER4—lymph node—sarcoma	0.00304	0.00563	CbGeAlD
Dinoprostone—SLCO2A1—cardiac atrium—sarcoma	0.00303	0.00561	CbGeAlD
Dinoprostone—SLCO2A1—uterus—sarcoma	0.00301	0.00558	CbGeAlD
Dinoprostone—SLC51A—lymph node—sarcoma	0.00298	0.00553	CbGeAlD
Dinoprostone—HPGDS—liver—sarcoma	0.0029	0.00537	CbGeAlD
Dinoprostone—Cardiac arrest—Vincristine—sarcoma	0.0029	0.00683	CcSEcCtD
Dinoprostone—Urinary retention—Vincristine—sarcoma	0.0029	0.00683	CcSEcCtD
Dinoprostone—SLCO2B1—hematopoietic system—sarcoma	0.00285	0.00529	CbGeAlD
Dinoprostone—PTGFR—testis—sarcoma	0.00284	0.00525	CbGeAlD
Dinoprostone—Dehydration—Vincristine—sarcoma	0.00283	0.00668	CcSEcCtD
Dinoprostone—SLCO4A1—cardiac atrium—sarcoma	0.00278	0.00516	CbGeAlD
Dinoprostone—ABCC5—cardiac atrium—sarcoma	0.00277	0.00513	CbGeAlD
Dinoprostone—Dehydration—Mitoxantrone—sarcoma	0.00276	0.0065	CcSEcCtD
Dinoprostone—PTGFR—liver—sarcoma	0.00268	0.00497	CbGeAlD
Dinoprostone—SLCO3A1—tendon—sarcoma	0.00266	0.00494	CbGeAlD
Dinoprostone—Laryngitis—Epirubicin—sarcoma	0.00264	0.00623	CcSEcCtD
Dinoprostone—SLCO2A1—tendon—sarcoma	0.00264	0.00489	CbGeAlD
Dinoprostone—SLCO1A2—hematopoietic system—sarcoma	0.00263	0.00487	CbGeAlD
Dinoprostone—PTGER3—lymph node—sarcoma	0.00257	0.00476	CbGeAlD
Dinoprostone—CYP19A1—hematopoietic system—sarcoma	0.00256	0.00475	CbGeAlD
Dinoprostone—Anaphylactoid reaction—Etoposide—sarcoma	0.00255	0.00601	CcSEcCtD
Dinoprostone—ABCC4—hematopoietic system—sarcoma	0.00253	0.00468	CbGeAlD
Dinoprostone—SLCO1C1—testis—sarcoma	0.00251	0.00465	CbGeAlD
Dinoprostone—SLC22A8—hematopoietic system—sarcoma	0.00251	0.00465	CbGeAlD
Dinoprostone—PTGIR—testis—sarcoma	0.0025	0.00463	CbGeAlD
Dinoprostone—Sweating increased—Mitoxantrone—sarcoma	0.0025	0.00589	CcSEcCtD
Dinoprostone—CYP19A1—connective tissue—sarcoma	0.00247	0.00457	CbGeAlD
Dinoprostone—Laryngitis—Doxorubicin—sarcoma	0.00245	0.00577	CcSEcCtD
Dinoprostone—ABCC5—tendon—sarcoma	0.00241	0.00447	CbGeAlD
Dinoprostone—SLC22A7—testis—sarcoma	0.00238	0.0044	CbGeAlD
Dinoprostone—PTGIR—liver—sarcoma	0.00236	0.00438	CbGeAlD
Dinoprostone—Cardiac arrest—Etoposide—sarcoma	0.00235	0.00553	CcSEcCtD
Dinoprostone—Pharyngitis—Dactinomycin—sarcoma	0.00234	0.00552	CcSEcCtD
Dinoprostone—ABCC5—bone marrow—sarcoma	0.00234	0.00433	CbGeAlD
Dinoprostone—Acute coronary syndrome—Vincristine—sarcoma	0.00231	0.00546	CcSEcCtD
Dinoprostone—SLC22A11—liver—sarcoma	0.0023	0.00427	CbGeAlD
Dinoprostone—Myocardial infarction—Vincristine—sarcoma	0.0023	0.00542	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00225	0.00531	CcSEcCtD
Dinoprostone—SLC22A7—liver—sarcoma	0.00225	0.00416	CbGeAlD
Dinoprostone—Myocardial infarction—Mitoxantrone—sarcoma	0.00224	0.00528	CcSEcCtD
Dinoprostone—HPGDS—lymph node—sarcoma	0.00222	0.00412	CbGeAlD
Dinoprostone—Cramp muscle—Etoposide—sarcoma	0.00222	0.00524	CcSEcCtD
Dinoprostone—SLCO3A1—testis—sarcoma	0.00221	0.00409	CbGeAlD
Dinoprostone—Flushing—Dactinomycin—sarcoma	0.00219	0.00516	CcSEcCtD
Dinoprostone—SLCO2A1—testis—sarcoma	0.00218	0.00405	CbGeAlD
Dinoprostone—CYP11A1—testis—sarcoma	0.00216	0.00401	CbGeAlD
Dinoprostone—Angiopathy—Thiotepa—sarcoma	0.00216	0.00508	CcSEcCtD
Dinoprostone—SLCO2B1—uterus—sarcoma	0.00216	0.00399	CbGeAlD
Dinoprostone—Immune system disorder—Thiotepa—sarcoma	0.00215	0.00506	CcSEcCtD
Dinoprostone—Chills—Thiotepa—sarcoma	0.00213	0.00503	CcSEcCtD
Dinoprostone—Arrhythmia—Thiotepa—sarcoma	0.00212	0.005	CcSEcCtD
Dinoprostone—Chills—Dactinomycin—sarcoma	0.00212	0.00499	CcSEcCtD
Dinoprostone—Skin discolouration—Epirubicin—sarcoma	0.00211	0.00497	CcSEcCtD
Dinoprostone—Bronchospasm—Etoposide—sarcoma	0.0021	0.00495	CcSEcCtD
Dinoprostone—SLCO3A1—liver—sarcoma	0.00209	0.00386	CbGeAlD
Dinoprostone—Sweating increased—Etoposide—sarcoma	0.00208	0.0049	CcSEcCtD
Dinoprostone—SLCO2A1—liver—sarcoma	0.00207	0.00383	CbGeAlD
Dinoprostone—PTGFR—lymph node—sarcoma	0.00206	0.00381	CbGeAlD
Dinoprostone—Pharyngitis—Mitoxantrone—sarcoma	0.00204	0.0048	CcSEcCtD
Dinoprostone—Tension—Thiotepa—sarcoma	0.00203	0.00479	CcSEcCtD
Dinoprostone—SLCO4A1—testis—sarcoma	0.00201	0.00372	CbGeAlD
Dinoprostone—Back pain—Thiotepa—sarcoma	0.002	0.00472	CcSEcCtD
Dinoprostone—ABCC5—testis—sarcoma	0.002	0.0037	CbGeAlD
Dinoprostone—Inflammation—Epirubicin—sarcoma	0.00196	0.00463	CcSEcCtD
Dinoprostone—Skin discolouration—Doxorubicin—sarcoma	0.00195	0.0046	CcSEcCtD
Dinoprostone—Vision blurred—Thiotepa—sarcoma	0.00195	0.0046	CcSEcCtD
Dinoprostone—CYP19A1—uterus—sarcoma	0.00194	0.00359	CbGeAlD
Dinoprostone—Angiopathy—Vincristine—sarcoma	0.00191	0.00451	CcSEcCtD
Dinoprostone—ABCC4—uterus—sarcoma	0.00191	0.00354	CbGeAlD
Dinoprostone—Hiccups—Epirubicin—sarcoma	0.00191	0.00449	CcSEcCtD
Dinoprostone—Vaginal inflammation—Epirubicin—sarcoma	0.00191	0.00449	CcSEcCtD
Dinoprostone—SLCO4A1—liver—sarcoma	0.0019	0.00352	CbGeAlD
Dinoprostone—ABCC5—liver—sarcoma	0.00189	0.0035	CbGeAlD
Dinoprostone—SLCO2B1—tendon—sarcoma	0.00189	0.0035	CbGeAlD
Dinoprostone—Acute coronary syndrome—Etoposide—sarcoma	0.00187	0.00442	CcSEcCtD
Dinoprostone—Myocardial infarction—Etoposide—sarcoma	0.00186	0.00439	CcSEcCtD
Dinoprostone—Chills—Mitoxantrone—sarcoma	0.00184	0.00434	CcSEcCtD
Dinoprostone—Arrhythmia—Mitoxantrone—sarcoma	0.00183	0.00432	CcSEcCtD
Dinoprostone—SLCO1C1—lymph node—sarcoma	0.00182	0.00337	CbGeAlD
Dinoprostone—Inflammation—Doxorubicin—sarcoma	0.00182	0.00429	CcSEcCtD
Dinoprostone—PTGIR—lymph node—sarcoma	0.00181	0.00336	CbGeAlD
Dinoprostone—Cough—Thiotepa—sarcoma	0.00181	0.00426	CcSEcCtD
Dinoprostone—Vaginal infection—Epirubicin—sarcoma	0.0018	0.00424	CcSEcCtD
Dinoprostone—Hypertension—Thiotepa—sarcoma	0.00179	0.00421	CcSEcCtD
Dinoprostone—Back pain—Vincristine—sarcoma	0.00177	0.00418	CcSEcCtD
Dinoprostone—Vaginal inflammation—Doxorubicin—sarcoma	0.00176	0.00416	CcSEcCtD
Dinoprostone—Hiccups—Doxorubicin—sarcoma	0.00176	0.00416	CcSEcCtD
Dinoprostone—Arthralgia—Thiotepa—sarcoma	0.00176	0.00415	CcSEcCtD
Dinoprostone—Myalgia—Thiotepa—sarcoma	0.00176	0.00415	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Epirubicin—sarcoma	0.00175	0.00413	CcSEcCtD
Dinoprostone—Myalgia—Dactinomycin—sarcoma	0.00175	0.00412	CcSEcCtD
Dinoprostone—Back pain—Mitoxantrone—sarcoma	0.00173	0.00407	CcSEcCtD
Dinoprostone—CYP1A2—hematopoietic system—sarcoma	0.00172	0.00318	CbGeAlD
Dinoprostone—Vision blurred—Mitoxantrone—sarcoma	0.00168	0.00397	CcSEcCtD
Dinoprostone—ABCC4—tendon—sarcoma	0.00167	0.0031	CbGeAlD
Dinoprostone—SLCO1B1—liver—sarcoma	0.00167	0.0031	CbGeAlD
Dinoprostone—Hypertonia—Epirubicin—sarcoma	0.00167	0.00394	CcSEcCtD
Dinoprostone—Vaginal infection—Doxorubicin—sarcoma	0.00166	0.00392	CcSEcCtD
Dinoprostone—Tachycardia—Thiotepa—sarcoma	0.00165	0.00388	CcSEcCtD
Dinoprostone—ABCC4—bone marrow—sarcoma	0.00162	0.003	CbGeAlD
Dinoprostone—Cramps of lower extremities—Doxorubicin—sarcoma	0.00162	0.00382	CcSEcCtD
Dinoprostone—SLCO3A1—lymph node—sarcoma	0.0016	0.00296	CbGeAlD
Dinoprostone—Flushing—Etoposide—sarcoma	0.00158	0.00373	CcSEcCtD
Dinoprostone—Hypertension—Vincristine—sarcoma	0.00158	0.00373	CcSEcCtD
Dinoprostone—SLCO2A1—lymph node—sarcoma	0.00158	0.00293	CbGeAlD
Dinoprostone—CYP11A1—lymph node—sarcoma	0.00157	0.0029	CbGeAlD
Dinoprostone—SLCO2B1—testis—sarcoma	0.00156	0.0029	CbGeAlD
Dinoprostone—Myalgia—Vincristine—sarcoma	0.00156	0.00368	CcSEcCtD
Dinoprostone—Cough—Mitoxantrone—sarcoma	0.00156	0.00368	CcSEcCtD
Dinoprostone—Angiopathy—Etoposide—sarcoma	0.00155	0.00365	CcSEcCtD
Dinoprostone—Hypertonia—Doxorubicin—sarcoma	0.00155	0.00364	CcSEcCtD
Dinoprostone—Hypertension—Mitoxantrone—sarcoma	0.00154	0.00364	CcSEcCtD
Dinoprostone—Immune system disorder—Etoposide—sarcoma	0.00154	0.00363	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00154	0.00363	CcSEcCtD
Dinoprostone—Eye pain—Epirubicin—sarcoma	0.00153	0.00361	CcSEcCtD
Dinoprostone—Chills—Etoposide—sarcoma	0.00153	0.00361	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00153	0.0036	CcSEcCtD
Dinoprostone—Myalgia—Mitoxantrone—sarcoma	0.00152	0.00359	CcSEcCtD
Dinoprostone—Arthralgia—Mitoxantrone—sarcoma	0.00152	0.00359	CcSEcCtD
Dinoprostone—Chest pain—Mitoxantrone—sarcoma	0.00152	0.00359	CcSEcCtD
Dinoprostone—Paraesthesia—Thiotepa—sarcoma	0.00152	0.00357	CcSEcCtD
Dinoprostone—Anaphylactic shock—Vincristine—sarcoma	0.0015	0.00353	CcSEcCtD
Dinoprostone—Hot flush—Epirubicin—sarcoma	0.00148	0.00349	CcSEcCtD
Dinoprostone—SLCO2B1—liver—sarcoma	0.00148	0.00274	CbGeAlD
Dinoprostone—Menopausal symptoms—Epirubicin—sarcoma	0.00147	0.00346	CcSEcCtD
Dinoprostone—Anaphylactic shock—Mitoxantrone—sarcoma	0.00146	0.00344	CcSEcCtD
Dinoprostone—SLCO4A1—lymph node—sarcoma	0.00146	0.0027	CbGeAlD
Dinoprostone—ABCC5—lymph node—sarcoma	0.00145	0.00268	CbGeAlD
Dinoprostone—Hyperhidrosis—Vincristine—sarcoma	0.00145	0.00341	CcSEcCtD
Dinoprostone—Pain—Thiotepa—sarcoma	0.00144	0.0034	CcSEcCtD
Dinoprostone—SLCO1A2—testis—sarcoma	0.00144	0.00267	CbGeAlD
Dinoprostone—Back pain—Etoposide—sarcoma	0.00144	0.00339	CcSEcCtD
Dinoprostone—Shock—Mitoxantrone—sarcoma	0.00143	0.00338	CcSEcCtD
Dinoprostone—Pain—Dactinomycin—sarcoma	0.00143	0.00338	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Epirubicin—sarcoma	0.00143	0.00337	CcSEcCtD
Dinoprostone—Muscle spasms—Etoposide—sarcoma	0.00143	0.00337	CcSEcCtD
Dinoprostone—Tachycardia—Mitoxantrone—sarcoma	0.00142	0.00335	CcSEcCtD
Dinoprostone—Eye pain—Doxorubicin—sarcoma	0.00142	0.00334	CcSEcCtD
Dinoprostone—SLC22A1—liver—sarcoma	0.00141	0.00262	CbGeAlD
Dinoprostone—Hyperhidrosis—Mitoxantrone—sarcoma	0.00141	0.00332	CcSEcCtD
Dinoprostone—CYP19A1—testis—sarcoma	0.0014	0.0026	CbGeAlD
Dinoprostone—Hypotension—Vincristine—sarcoma	0.0014	0.0033	CcSEcCtD
Dinoprostone—ABCC4—testis—sarcoma	0.00139	0.00257	CbGeAlD
Dinoprostone—Gastrointestinal pain—Thiotepa—sarcoma	0.00138	0.00325	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Dactinomycin—sarcoma	0.00137	0.00323	CcSEcCtD
Dinoprostone—Hot flush—Doxorubicin—sarcoma	0.00137	0.00323	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Vincristine—sarcoma	0.00136	0.00322	CcSEcCtD
Dinoprostone—Hypotension—Mitoxantrone—sarcoma	0.00136	0.00321	CcSEcCtD
Dinoprostone—SLCO1A2—liver—sarcoma	0.00136	0.00252	CbGeAlD
Dinoprostone—Menopausal symptoms—Doxorubicin—sarcoma	0.00136	0.0032	CcSEcCtD
Dinoprostone—Paraesthesia—Vincristine—sarcoma	0.00134	0.00317	CcSEcCtD
Dinoprostone—Abdominal pain—Thiotepa—sarcoma	0.00133	0.00315	CcSEcCtD
Dinoprostone—Body temperature increased—Thiotepa—sarcoma	0.00133	0.00315	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00133	0.00313	CcSEcCtD
Dinoprostone—CYP19A1—liver—sarcoma	0.00133	0.00246	CbGeAlD
Dinoprostone—Abdominal pain—Dactinomycin—sarcoma	0.00132	0.00312	CcSEcCtD
Dinoprostone—Body temperature increased—Dactinomycin—sarcoma	0.00132	0.00312	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00132	0.00312	CcSEcCtD
Dinoprostone—Cardiac arrest—Epirubicin—sarcoma	0.00132	0.0031	CcSEcCtD
Dinoprostone—ABCC4—liver—sarcoma	0.00131	0.00243	CbGeAlD
Dinoprostone—Paraesthesia—Mitoxantrone—sarcoma	0.00131	0.00309	CcSEcCtD
Dinoprostone—Loss of consciousness—Etoposide—sarcoma	0.00131	0.00308	CcSEcCtD
Dinoprostone—Dyspnoea—Mitoxantrone—sarcoma	0.0013	0.00306	CcSEcCtD
Dinoprostone—Cough—Etoposide—sarcoma	0.0013	0.00306	CcSEcCtD
Dinoprostone—Dehydration—Epirubicin—sarcoma	0.00129	0.00303	CcSEcCtD
Dinoprostone—Hypertension—Etoposide—sarcoma	0.00128	0.00302	CcSEcCtD
Dinoprostone—Pain—Vincristine—sarcoma	0.00128	0.00302	CcSEcCtD
Dinoprostone—Chest pain—Etoposide—sarcoma	0.00127	0.00298	CcSEcCtD
Dinoprostone—Pain—Mitoxantrone—sarcoma	0.00125	0.00294	CcSEcCtD
Dinoprostone—Hypersensitivity—Thiotepa—sarcoma	0.00124	0.00293	CcSEcCtD
Dinoprostone—Hypersensitivity—Dactinomycin—sarcoma	0.00123	0.00291	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Vincristine—sarcoma	0.00122	0.00289	CcSEcCtD
Dinoprostone—Cardiac arrest—Doxorubicin—sarcoma	0.00122	0.00287	CcSEcCtD
Dinoprostone—Anaphylactic shock—Etoposide—sarcoma	0.00121	0.00286	CcSEcCtD
Dinoprostone—Asthenia—Thiotepa—sarcoma	0.00121	0.00286	CcSEcCtD
Dinoprostone—Asthenia—Dactinomycin—sarcoma	0.0012	0.00283	CcSEcCtD
Dinoprostone—Asthma—Epirubicin—sarcoma	0.0012	0.00282	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00119	0.00281	CcSEcCtD
Dinoprostone—Dehydration—Doxorubicin—sarcoma	0.00119	0.00281	CcSEcCtD
Dinoprostone—Tachycardia—Etoposide—sarcoma	0.00118	0.00279	CcSEcCtD
Dinoprostone—Abdominal pain—Vincristine—sarcoma	0.00118	0.00279	CcSEcCtD
Dinoprostone—Body temperature increased—Vincristine—sarcoma	0.00118	0.00279	CcSEcCtD
Dinoprostone—Hyperhidrosis—Etoposide—sarcoma	0.00117	0.00276	CcSEcCtD
Dinoprostone—Diarrhoea—Thiotepa—sarcoma	0.00116	0.00272	CcSEcCtD
Dinoprostone—Body temperature increased—Mitoxantrone—sarcoma	0.00115	0.00272	CcSEcCtD
Dinoprostone—Abdominal pain—Mitoxantrone—sarcoma	0.00115	0.00272	CcSEcCtD
Dinoprostone—Diarrhoea—Dactinomycin—sarcoma	0.00115	0.0027	CcSEcCtD
Dinoprostone—SLCO2B1—lymph node—sarcoma	0.00113	0.0021	CbGeAlD
Dinoprostone—Hypotension—Etoposide—sarcoma	0.00113	0.00267	CcSEcCtD
Dinoprostone—Dizziness—Thiotepa—sarcoma	0.00112	0.00263	CcSEcCtD
Dinoprostone—Asthma—Doxorubicin—sarcoma	0.00111	0.00261	CcSEcCtD
Dinoprostone—Hypersensitivity—Vincristine—sarcoma	0.0011	0.0026	CcSEcCtD
Dinoprostone—Paraesthesia—Etoposide—sarcoma	0.00109	0.00257	CcSEcCtD
Dinoprostone—Dyspnoea—Etoposide—sarcoma	0.00108	0.00255	CcSEcCtD
Dinoprostone—Hypersensitivity—Mitoxantrone—sarcoma	0.00107	0.00253	CcSEcCtD
Dinoprostone—Asthenia—Vincristine—sarcoma	0.00107	0.00253	CcSEcCtD
Dinoprostone—Vomiting—Thiotepa—sarcoma	0.00107	0.00253	CcSEcCtD
Dinoprostone—Vomiting—Dactinomycin—sarcoma	0.00107	0.00251	CcSEcCtD
Dinoprostone—Rash—Thiotepa—sarcoma	0.00106	0.00251	CcSEcCtD
Dinoprostone—Dermatitis—Thiotepa—sarcoma	0.00106	0.00251	CcSEcCtD
Dinoprostone—Headache—Thiotepa—sarcoma	0.00106	0.00249	CcSEcCtD
Dinoprostone—Rash—Dactinomycin—sarcoma	0.00106	0.00249	CcSEcCtD
Dinoprostone—Asthenia—Mitoxantrone—sarcoma	0.00105	0.00247	CcSEcCtD
Dinoprostone—Pain—Etoposide—sarcoma	0.00104	0.00244	CcSEcCtD
Dinoprostone—Diarrhoea—Vincristine—sarcoma	0.00102	0.00241	CcSEcCtD
Dinoprostone—CYP19A1—lymph node—sarcoma	0.00102	0.00189	CbGeAlD
Dinoprostone—ABCC4—lymph node—sarcoma	0.001	0.00186	CbGeAlD
Dinoprostone—Nausea—Thiotepa—sarcoma	0.001	0.00236	CcSEcCtD
Dinoprostone—Diarrhoea—Mitoxantrone—sarcoma	0.000998	0.00235	CcSEcCtD
Dinoprostone—Nausea—Dactinomycin—sarcoma	0.000995	0.00235	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Etoposide—sarcoma	0.000992	0.00234	CcSEcCtD
Dinoprostone—Dizziness—Vincristine—sarcoma	0.00099	0.00233	CcSEcCtD
Dinoprostone—Body temperature increased—Etoposide—sarcoma	0.000959	0.00226	CcSEcCtD
Dinoprostone—Abdominal pain—Etoposide—sarcoma	0.000959	0.00226	CcSEcCtD
Dinoprostone—Vomiting—Vincristine—sarcoma	0.000952	0.00224	CcSEcCtD
Dinoprostone—Pharyngitis—Epirubicin—sarcoma	0.00095	0.00224	CcSEcCtD
Dinoprostone—Rash—Vincristine—sarcoma	0.000944	0.00223	CcSEcCtD
Dinoprostone—Dermatitis—Vincristine—sarcoma	0.000943	0.00222	CcSEcCtD
Dinoprostone—Headache—Vincristine—sarcoma	0.000938	0.00221	CcSEcCtD
Dinoprostone—Vomiting—Mitoxantrone—sarcoma	0.000927	0.00219	CcSEcCtD
Dinoprostone—Rash—Mitoxantrone—sarcoma	0.000919	0.00217	CcSEcCtD
Dinoprostone—Dermatitis—Mitoxantrone—sarcoma	0.000919	0.00217	CcSEcCtD
Dinoprostone—Headache—Mitoxantrone—sarcoma	0.000913	0.00215	CcSEcCtD
Dinoprostone—Hypersensitivity—Etoposide—sarcoma	0.000894	0.00211	CcSEcCtD
Dinoprostone—CYP1A2—liver—sarcoma	0.00089	0.00165	CbGeAlD
Dinoprostone—Nausea—Vincristine—sarcoma	0.000889	0.0021	CcSEcCtD
Dinoprostone—Flushing—Epirubicin—sarcoma	0.000888	0.00209	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—sarcoma	0.000879	0.00207	CcSEcCtD
Dinoprostone—Asthenia—Etoposide—sarcoma	0.00087	0.00205	CcSEcCtD
Dinoprostone—Angiopathy—Epirubicin—sarcoma	0.000868	0.00205	CcSEcCtD
Dinoprostone—Nausea—Mitoxantrone—sarcoma	0.000866	0.00204	CcSEcCtD
Dinoprostone—Immune system disorder—Epirubicin—sarcoma	0.000864	0.00204	CcSEcCtD
Dinoprostone—Chills—Epirubicin—sarcoma	0.000859	0.00202	CcSEcCtD
Dinoprostone—Arrhythmia—Epirubicin—sarcoma	0.000855	0.00202	CcSEcCtD
Dinoprostone—Diarrhoea—Etoposide—sarcoma	0.00083	0.00196	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—sarcoma	0.000822	0.00194	CcSEcCtD
Dinoprostone—Tension—Epirubicin—sarcoma	0.000817	0.00193	CcSEcCtD
Dinoprostone—Back pain—Epirubicin—sarcoma	0.000806	0.0019	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—sarcoma	0.000803	0.00189	CcSEcCtD
Dinoprostone—Dizziness—Etoposide—sarcoma	0.000802	0.00189	CcSEcCtD
Dinoprostone—Muscle spasms—Epirubicin—sarcoma	0.000801	0.00189	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—sarcoma	0.0008	0.00189	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—sarcoma	0.000794	0.00187	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—sarcoma	0.000791	0.00186	CcSEcCtD
Dinoprostone—Vision blurred—Epirubicin—sarcoma	0.000785	0.00185	CcSEcCtD
Dinoprostone—Vomiting—Etoposide—sarcoma	0.000771	0.00182	CcSEcCtD
Dinoprostone—Rash—Etoposide—sarcoma	0.000765	0.0018	CcSEcCtD
Dinoprostone—Dermatitis—Etoposide—sarcoma	0.000764	0.0018	CcSEcCtD
Dinoprostone—Headache—Etoposide—sarcoma	0.00076	0.00179	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—sarcoma	0.000756	0.00178	CcSEcCtD
Dinoprostone—Syncope—Epirubicin—sarcoma	0.000747	0.00176	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—sarcoma	0.000746	0.00176	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—sarcoma	0.000741	0.00175	CcSEcCtD
Dinoprostone—Loss of consciousness—Epirubicin—sarcoma	0.000732	0.00173	CcSEcCtD
Dinoprostone—Cough—Epirubicin—sarcoma	0.000727	0.00171	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—sarcoma	0.000726	0.00171	CcSEcCtD
Dinoprostone—Nausea—Etoposide—sarcoma	0.00072	0.0017	CcSEcCtD
Dinoprostone—Hypertension—Epirubicin—sarcoma	0.000719	0.0017	CcSEcCtD
Dinoprostone—Chest pain—Epirubicin—sarcoma	0.000709	0.00167	CcSEcCtD
Dinoprostone—Arthralgia—Epirubicin—sarcoma	0.000709	0.00167	CcSEcCtD
Dinoprostone—Myalgia—Epirubicin—sarcoma	0.000709	0.00167	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—sarcoma	0.000691	0.00163	CcSEcCtD
Dinoprostone—Anaphylactic shock—Epirubicin—sarcoma	0.00068	0.0016	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—sarcoma	0.000677	0.0016	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—sarcoma	0.000673	0.00159	CcSEcCtD
Dinoprostone—Shock—Epirubicin—sarcoma	0.000669	0.00158	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—sarcoma	0.000665	0.00157	CcSEcCtD
Dinoprostone—Tachycardia—Epirubicin—sarcoma	0.000664	0.00156	CcSEcCtD
Dinoprostone—Hyperhidrosis—Epirubicin—sarcoma	0.000657	0.00155	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—sarcoma	0.000656	0.00155	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—sarcoma	0.000656	0.00155	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—sarcoma	0.000656	0.00155	CcSEcCtD
Dinoprostone—Hypotension—Epirubicin—sarcoma	0.000635	0.0015	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—sarcoma	0.000629	0.00148	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000619	0.00146	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—sarcoma	0.000619	0.00146	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—sarcoma	0.000614	0.00145	CcSEcCtD
Dinoprostone—Paraesthesia—Epirubicin—sarcoma	0.00061	0.00144	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—sarcoma	0.000608	0.00143	CcSEcCtD
Dinoprostone—Dyspnoea—Epirubicin—sarcoma	0.000606	0.00143	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—sarcoma	0.000588	0.00139	CcSEcCtD
Dinoprostone—Pain—Epirubicin—sarcoma	0.000581	0.00137	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000573	0.00135	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—sarcoma	0.000565	0.00133	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—sarcoma	0.000561	0.00132	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Epirubicin—sarcoma	0.000556	0.00131	CcSEcCtD
Dinoprostone—Pain—Doxorubicin—sarcoma	0.000538	0.00127	CcSEcCtD
Dinoprostone—Abdominal pain—Epirubicin—sarcoma	0.000537	0.00127	CcSEcCtD
Dinoprostone—Body temperature increased—Epirubicin—sarcoma	0.000537	0.00127	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000514	0.00121	CcSEcCtD
Dinoprostone—Hypersensitivity—Epirubicin—sarcoma	0.000501	0.00118	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—sarcoma	0.000497	0.00117	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—sarcoma	0.000497	0.00117	CcSEcCtD
Dinoprostone—Asthenia—Epirubicin—sarcoma	0.000488	0.00115	CcSEcCtD
Dinoprostone—Diarrhoea—Epirubicin—sarcoma	0.000465	0.0011	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—sarcoma	0.000463	0.00109	CcSEcCtD
Dinoprostone—Asthenia—Doxorubicin—sarcoma	0.000451	0.00106	CcSEcCtD
Dinoprostone—Dizziness—Epirubicin—sarcoma	0.00045	0.00106	CcSEcCtD
Dinoprostone—Vomiting—Epirubicin—sarcoma	0.000432	0.00102	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—sarcoma	0.00043	0.00101	CcSEcCtD
Dinoprostone—Rash—Epirubicin—sarcoma	0.000429	0.00101	CcSEcCtD
Dinoprostone—Dermatitis—Epirubicin—sarcoma	0.000428	0.00101	CcSEcCtD
Dinoprostone—Headache—Epirubicin—sarcoma	0.000426	0.001	CcSEcCtD
Dinoprostone—Dizziness—Doxorubicin—sarcoma	0.000416	0.000981	CcSEcCtD
Dinoprostone—Nausea—Epirubicin—sarcoma	0.000404	0.000952	CcSEcCtD
Dinoprostone—Vomiting—Doxorubicin—sarcoma	0.0004	0.000943	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—sarcoma	0.000397	0.000935	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—sarcoma	0.000396	0.000934	CcSEcCtD
Dinoprostone—Headache—Doxorubicin—sarcoma	0.000394	0.000929	CcSEcCtD
Dinoprostone—Nausea—Doxorubicin—sarcoma	0.000374	0.000881	CcSEcCtD
Dinoprostone—PTGER4—Signaling Pathways—PDGFRB—sarcoma	5.31e-05	0.00147	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFC—sarcoma	5.29e-05	0.00147	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFC—sarcoma	5.29e-05	0.00147	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	5.23e-05	0.00145	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	5.23e-05	0.00145	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PDGFRA—sarcoma	5.22e-05	0.00145	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	5.2e-05	0.00144	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PLCG1—sarcoma	5.1e-05	0.00142	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	5.09e-05	0.00141	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ENO2—sarcoma	5.04e-05	0.0014	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	5.03e-05	0.0014	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—HBA1—sarcoma	5e-05	0.00139	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—CREB1—sarcoma	4.95e-05	0.00137	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CXCR4—sarcoma	4.9e-05	0.00136	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL2—sarcoma	4.82e-05	0.00134	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	4.79e-05	0.00133	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	4.74e-05	0.00132	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—SRC—sarcoma	4.71e-05	0.00131	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	4.68e-05	0.0013	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	4.68e-05	0.0013	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—IL2—sarcoma	4.66e-05	0.00129	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IGF1R—sarcoma	4.59e-05	0.00127	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—VEGFA—sarcoma	4.58e-05	0.00127	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	4.58e-05	0.00127	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	4.58e-05	0.00127	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	4.42e-05	0.00123	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—MDM2—sarcoma	4.42e-05	0.00123	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ENO2—sarcoma	4.41e-05	0.00122	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—KDR—sarcoma	4.4e-05	0.00122	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—CREB1—sarcoma	4.39e-05	0.00122	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—HBA1—sarcoma	4.38e-05	0.00122	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—FOXO1—sarcoma	4.36e-05	0.00121	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—IL2—sarcoma	4.36e-05	0.00121	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PDGFRB—sarcoma	4.36e-05	0.00121	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	4.33e-05	0.0012	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—FLT1—sarcoma	4.32e-05	0.0012	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PDGFRA—sarcoma	4.29e-05	0.00119	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PLCG1—sarcoma	4.27e-05	0.00119	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PLCG1—sarcoma	4.25e-05	0.00118	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IGF1R—sarcoma	4.23e-05	0.00117	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—FLT1—sarcoma	4.23e-05	0.00117	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—FLT1—sarcoma	4.23e-05	0.00117	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PLCG1—sarcoma	4.16e-05	0.00115	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PLCG1—sarcoma	4.16e-05	0.00115	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—CREB1—sarcoma	4.09e-05	0.00114	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCR4—sarcoma	4.08e-05	0.00113	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—SRC—sarcoma	4.07e-05	0.00113	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—KIT—sarcoma	4.05e-05	0.00112	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—NRAS—sarcoma	4.05e-05	0.00112	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ATF1—sarcoma	4.03e-05	0.00112	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—FOXO1—sarcoma	4.03e-05	0.00112	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—IL2—sarcoma	4.03e-05	0.00112	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PDGFRB—sarcoma	4.02e-05	0.00112	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCR4—sarcoma	3.99e-05	0.00111	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCR4—sarcoma	3.99e-05	0.00111	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—VEGFA—sarcoma	3.96e-05	0.0011	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL2—sarcoma	3.96e-05	0.0011	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PDGFRA—sarcoma	3.96e-05	0.0011	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ATF1—sarcoma	3.95e-05	0.0011	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ATF1—sarcoma	3.95e-05	0.0011	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	3.93e-05	0.00109	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—NRAS—sarcoma	3.91e-05	0.00109	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CREB1—sarcoma	3.86e-05	0.00107	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PLCG1—sarcoma	3.74e-05	0.00104	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—CREB1—sarcoma	3.7e-05	0.00103	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—EGFR—sarcoma	3.69e-05	0.00102	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	3.68e-05	0.00102	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL2—sarcoma	3.66e-05	0.00101	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—MDM2—sarcoma	3.63e-05	0.00101	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—FOXO1—sarcoma	3.62e-05	0.001	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—CREB1—sarcoma	3.62e-05	0.001	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—CREB1—sarcoma	3.62e-05	0.001	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PDGFRB—sarcoma	3.61e-05	0.001	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KDR—sarcoma	3.61e-05	0.001	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PDGFRA—sarcoma	3.56e-05	0.000987	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—KRAS—sarcoma	3.49e-05	0.000967	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—MDM2—sarcoma	3.39e-05	0.00094	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—KRAS—sarcoma	3.37e-05	0.000935	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KDR—sarcoma	3.33e-05	0.000925	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KIT—sarcoma	3.33e-05	0.000923	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—NRAS—sarcoma	3.33e-05	0.000923	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ENO2—sarcoma	3.23e-05	0.000897	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—HBA1—sarcoma	3.21e-05	0.000892	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MDM2—sarcoma	3.19e-05	0.000885	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CREB1—sarcoma	3.17e-05	0.000879	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IGF1R—sarcoma	3.16e-05	0.000878	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IGF1R—sarcoma	3.1e-05	0.00086	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IGF1R—sarcoma	3.1e-05	0.00086	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KIT—sarcoma	3.07e-05	0.000852	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—NRAS—sarcoma	3.07e-05	0.000852	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—EGFR—sarcoma	3.03e-05	0.000841	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—FOXO1—sarcoma	3.01e-05	0.000836	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—IL2—sarcoma	3.01e-05	0.000835	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PDGFRB—sarcoma	3.01e-05	0.000834	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TP53—sarcoma	2.99e-05	0.000831	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—HRAS—sarcoma	2.96e-05	0.000822	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PDGFRA—sarcoma	2.96e-05	0.000821	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—FOXO1—sarcoma	2.95e-05	0.000818	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—FOXO1—sarcoma	2.95e-05	0.000818	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—IL2—sarcoma	2.95e-05	0.000818	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—IL2—sarcoma	2.95e-05	0.000818	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PDGFRB—sarcoma	2.94e-05	0.000817	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PDGFRB—sarcoma	2.94e-05	0.000817	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ENO2—sarcoma	2.92e-05	0.000811	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CREB1—sarcoma	2.92e-05	0.000811	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—HBA1—sarcoma	2.9e-05	0.000806	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PDGFRA—sarcoma	2.9e-05	0.000804	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PDGFRA—sarcoma	2.9e-05	0.000804	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—HRAS—sarcoma	2.86e-05	0.000795	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—KRAS—sarcoma	2.86e-05	0.000794	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL2—sarcoma	2.85e-05	0.000791	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—EGFR—sarcoma	2.8e-05	0.000776	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—IL2—sarcoma	2.78e-05	0.000771	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CCND1—sarcoma	2.78e-05	0.000771	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—JUN—sarcoma	2.77e-05	0.000769	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ENO2—sarcoma	2.76e-05	0.000767	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KIT—sarcoma	2.76e-05	0.000766	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CTNNB1—sarcoma	2.75e-05	0.000763	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—HBA1—sarcoma	2.75e-05	0.000762	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PLCG1—sarcoma	2.74e-05	0.000761	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL2—sarcoma	2.73e-05	0.000759	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL2—sarcoma	2.68e-05	0.000743	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL2—sarcoma	2.68e-05	0.000743	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—KRAS—sarcoma	2.64e-05	0.000733	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CREB1—sarcoma	2.63e-05	0.000729	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MDM2—sarcoma	2.62e-05	0.000727	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	2.6e-05	0.000722	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ENO2—sarcoma	2.53e-05	0.000703	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HBA1—sarcoma	2.52e-05	0.000699	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KDR—sarcoma	2.49e-05	0.000691	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—SRC—sarcoma	2.49e-05	0.00069	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PLCG1—sarcoma	2.48e-05	0.000688	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KDR—sarcoma	2.44e-05	0.000677	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KDR—sarcoma	2.44e-05	0.000677	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—HRAS—sarcoma	2.43e-05	0.000675	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—HRAS—sarcoma	2.43e-05	0.000673	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—SRC—sarcoma	2.43e-05	0.000673	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VEGFA—sarcoma	2.42e-05	0.000672	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MDM2—sarcoma	2.42e-05	0.000671	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—NRAS—sarcoma	2.39e-05	0.000664	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—sarcoma	2.36e-05	0.000655	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ENO2—sarcoma	2.36e-05	0.000655	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HBA1—sarcoma	2.35e-05	0.000651	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PLCG1—sarcoma	2.35e-05	0.000651	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL2—sarcoma	2.34e-05	0.000649	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—NRAS—sarcoma	2.33e-05	0.000647	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KIT—sarcoma	2.3e-05	0.000637	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—NRAS—sarcoma	2.3e-05	0.000637	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CCND1—sarcoma	2.28e-05	0.000633	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—JUN—sarcoma	2.28e-05	0.000632	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CTNNB1—sarcoma	2.26e-05	0.000627	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KIT—sarcoma	2.25e-05	0.000623	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KIT—sarcoma	2.25e-05	0.000623	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—NRAS—sarcoma	2.25e-05	0.000623	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—NRAS—sarcoma	2.25e-05	0.000623	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—HRAS—sarcoma	2.25e-05	0.000623	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MYC—sarcoma	2.23e-05	0.000618	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CREB1—sarcoma	2.18e-05	0.000606	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EGFR—sarcoma	2.18e-05	0.000605	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MDM2—sarcoma	2.17e-05	0.000603	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL2—sarcoma	2.16e-05	0.000599	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PLCG1—sarcoma	2.15e-05	0.000597	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CREB1—sarcoma	2.14e-05	0.000593	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CREB1—sarcoma	2.14e-05	0.000593	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCND1—sarcoma	2.11e-05	0.000584	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—JUN—sarcoma	2.1e-05	0.000583	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—EGFR—sarcoma	2.09e-05	0.00058	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CTNNB1—sarcoma	2.09e-05	0.000579	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—KRAS—sarcoma	2.06e-05	0.000571	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—EGFR—sarcoma	2.05e-05	0.000568	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—EGFR—sarcoma	2.05e-05	0.000568	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SRC—sarcoma	2.04e-05	0.000567	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—KRAS—sarcoma	2.01e-05	0.000557	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PLCG1—sarcoma	2e-05	0.000556	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—HRAS—sarcoma	1.99e-05	0.000553	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—sarcoma	1.99e-05	0.000552	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—KRAS—sarcoma	1.98e-05	0.000548	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—NRAS—sarcoma	1.96e-05	0.000545	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—KRAS—sarcoma	1.93e-05	0.000537	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—KRAS—sarcoma	1.93e-05	0.000537	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SRC—sarcoma	1.88e-05	0.000523	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CTNNB1—sarcoma	1.87e-05	0.00052	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—HRAS—sarcoma	1.86e-05	0.000516	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—sarcoma	1.84e-05	0.000509	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—sarcoma	1.83e-05	0.000508	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—sarcoma	1.83e-05	0.000508	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NRAS—sarcoma	1.81e-05	0.000503	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MDM2—sarcoma	1.81e-05	0.000502	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—sarcoma	1.79e-05	0.000497	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—sarcoma	1.78e-05	0.000495	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MDM2—sarcoma	1.77e-05	0.000491	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MDM2—sarcoma	1.77e-05	0.000491	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—sarcoma	1.75e-05	0.000486	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—sarcoma	1.71e-05	0.000474	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SRC—sarcoma	1.69e-05	0.00047	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—sarcoma	1.69e-05	0.000469	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—sarcoma	1.69e-05	0.000469	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—sarcoma	1.68e-05	0.000466	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—sarcoma	1.65e-05	0.000458	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—sarcoma	1.64e-05	0.000456	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—sarcoma	1.64e-05	0.000456	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NRAS—sarcoma	1.63e-05	0.000452	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2—sarcoma	1.62e-05	0.000448	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2—sarcoma	1.58e-05	0.000439	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2—sarcoma	1.58e-05	0.000439	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—sarcoma	1.57e-05	0.000437	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—JUN—sarcoma	1.57e-05	0.000436	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—sarcoma	1.56e-05	0.000433	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CTNNB1—sarcoma	1.56e-05	0.000433	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—sarcoma	1.54e-05	0.000428	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—sarcoma	1.54e-05	0.000428	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—JUN—sarcoma	1.54e-05	0.000427	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—JUN—sarcoma	1.54e-05	0.000427	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CTNNB1—sarcoma	1.53e-05	0.000424	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CTNNB1—sarcoma	1.53e-05	0.000424	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—sarcoma	1.52e-05	0.000421	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—sarcoma	1.5e-05	0.000417	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—sarcoma	1.48e-05	0.000412	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—sarcoma	1.44e-05	0.000399	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SRC—sarcoma	1.41e-05	0.000391	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—sarcoma	1.4e-05	0.000389	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—sarcoma	1.39e-05	0.000385	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SRC—sarcoma	1.38e-05	0.000383	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SRC—sarcoma	1.38e-05	0.000383	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—sarcoma	1.37e-05	0.000381	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRAS—sarcoma	1.36e-05	0.000376	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—sarcoma	1.34e-05	0.000373	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—sarcoma	1.34e-05	0.000373	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRAS—sarcoma	1.33e-05	0.000368	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRAS—sarcoma	1.33e-05	0.000368	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—sarcoma	1.33e-05	0.000368	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—sarcoma	1.26e-05	0.00035	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—sarcoma	1.24e-05	0.000343	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—sarcoma	1.24e-05	0.000343	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—sarcoma	1.24e-05	0.000343	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—sarcoma	1.21e-05	0.000336	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—sarcoma	1.21e-05	0.000336	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—sarcoma	1.19e-05	0.000331	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—sarcoma	1.17e-05	0.000324	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—sarcoma	1.14e-05	0.000317	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—sarcoma	1.14e-05	0.000317	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO2—sarcoma	1.1e-05	0.000307	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HBA1—sarcoma	1.1e-05	0.000305	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—sarcoma	1.04e-05	0.000288	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—sarcoma	1.02e-05	0.000282	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—sarcoma	1.02e-05	0.000282	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—sarcoma	9.92e-06	0.000275	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—sarcoma	9.71e-06	0.000269	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—sarcoma	9.71e-06	0.000269	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLCG1—sarcoma	9.37e-06	0.00026	CbGpPWpGaD
